TrialPanorama/Dataset huggingface dataset:
Please assess the completion status of the following clinical trial:

Trial Title: Impact of Chemotherapy on Ovarian Reserve in Young Women With Breast Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* female 18-39 years~* suffering from breast cancer~* treated with adjuvant or neoadjuvant chemotherapy

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 39 Years
- Healthy Volunteers: f

Study Arms:
- young women with breast cancer (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: lack of efficacy
Please assess the completion status of the following clinical trial:

Trial Title: Increasing Infant Preventive Health Service Delivery in an Inner City Population

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Any child born at Denver Health Medical Center between 2/1/04 and 1/31/05 who receives primary care at one of 3 community health centers.~Exclusion Criteria:~* No medical care in the Denver Health community health system after 42 days of age.~* Birthweight less than 1500 grams.

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Historical Cohort (Type: NO_INTERVENTION): This study will first examine risk factors in a defined population of inner city children, using a historical cohort.
- Reminder Recall Outreach (Type: ACTIVE_COMPARATOR): To determine how well Reminder Recall Outreach will increase immunization rates and well child care delivery in those children most at risk for falling through the cracks. These studies will be conducted in the Denver Health community health network, the largest integrated community health care system in the United States.
- Case Management (Type: ACTIVE_COMPARATOR): To determine how well Case Management will increase immunization rates and well child care delivery in those children most at risk for falling through the cracks. These studies will be conducted in the Denver Health community health network, the largest integrated community health care system in the United States.
- Patient Navigation (Type: ACTIVE_COMPARATOR): To determine how well Patient Navigation will increase immunization rates and well child care delivery in those children most at risk for falling through the cracks. These studies will be conducted in the Denver Health community health network, the largest integrated community health care system in the United States.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: regulatory/approval
Please assess the completion status of the following clinical trial:

Trial Title: Pregnancy, Mindfulness, and Massage

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* currently pregnant in third trimester~* singleton pregnancy~* aged 18 years or older~* women smoked before their pregnancy~* women who currently smoke at least 5 cigarettes per day at enrollment~* women need access to a smartphone~* women expressing an interest in learning skills to help decrease tobacco-smoking~Exclusion Criteria:~* incapable of giving informed consent~* insufficient English fluency~* participating in other smoking cessation programs~* evidencing severe psychiatric symptoms

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Massage Therapy and Mindfulness (Type: EXPERIMENTAL): Participants in the intervention group will receive two prenatal massages a week for a three-week period. They will also be enrolled in the mindfulness-based Craving to Quit® tobacco cessation program during this 3-week period.
- Mindfulness (Type: ACTIVE_COMPARATOR): Participants will enroll in the mindfulness-based Craving to Quit® tobacco cessation program during the same 3-week period. A massage will be provided upon completion of the study.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: enrollment issues
Please assess the completion status of the following clinical trial:

Trial Title: Risk Factors for Coronary Artery Calcification and Left Ventricular Hypertrophy in Hemodialysis Patients

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Adults (≥ 18 years of age) commencing hemodialysis or peritoneal dialysis.~Exclusion Criteria:~• Unable to provide informed consent.~Exclusion Criteria for the cardiac substudy:~CT exclusion criteria~1. Pregnancy~2. Obesity (\>275 lbs)~3. Rapid atrial fibrillation, bigeminy or trigeminy~4. Any condition that impedes the ability to lie flat during the CT (eg:decompensated congestive heart failure).~MRI exclusion criteria~1. Cardiac pacemaker or implantable defibrillator~2. Obesity (\>275lbs)~3. Intraocular metal~4. Cerebral aneurysm clips, programmable shunt, etc.~5. Any type of ear implant~6. Any implanted device (eg: insulin, drug infusion device)~7. Metal shrapnel or bullet~8. Any condition that impedes the ability to lie flat during the MRI (eg:decompensated congestive heart failure)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: enrollment issues
Please assess the completion status of the following clinical trial:

Trial Title: Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patient requiring a hypofractionated irradiation (≥ 3 fractions, dose ≥ 9 Gy per fraction) either for :~* hepatocellular carcinoma or hepatic lesion of metastatic Colorectal Cancer,~* metastasis from melanoma or renal cancer,~* Age ≥ 18 years old,~* Registered with a social security system,~* Signed written informed consent.~Exclusion Criteria:~* Patient treated by chemotherapy, targeted or immunotherapy within 21 days before the first sampling,~* Pregnant or breastfeeding woman,~* Patient under guardianship or tutorship.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Blood samples collection (Type: EXPERIMENTAL): Nine blood samples will be collected in each patient before, during and after radiotherapy treatment.~Interventions :~* Blood samples collection before radiotherapy (T0)~* Blood samples collection during radiotherapy (T1-T3)~* Blood samples collection after radiotherapy (T4-T8)

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: enrollment issues
Please assess the completion status of the following clinical trial:

Trial Title: Qp/Qs Ratio by Noninvasive Methods in Children With Shunt Dependent Pulmonary Circulation

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. pediatric cardiac patients scheduled to cardiac operation (shunt dependent pulmonary circulation)~2. preoperative SpO2\<97%~Exclusion Criteria:~1. unable to measure pulse oximeter or cerebral oximeter signal~2. unable to measure SaO2 or SmvO2~3. unstable vital sign

- Gender: ALL
- Minimum Age: None
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Qp/Qs ratio monitoring (Type: None): Qp/Qs ratio monitoring

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: feasibility
Please assess the completion status of the following clinical trial:

Trial Title: Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Histologically proven stage II-IV adenocarcinoma of the stomach including cardia carcinoma types II and III~  * Locally resectable disease~ * No distant metastases except M1 lymph nodes~ * No evidence of peritoneal carcinomatosis~    * Free tumor cells in lavage at laparoscopy allowed~* No uncontrolled bleeding of the primary tumor~* No gastric outlet syndrome or complete tumor stenosis that would require total parenteral nutrition~PATIENT CHARACTERISTICS:~Age:~* 18 to 69~Performance status:~* WHO 0-1~Life expectancy:~* Not specified~Hematopoietic:~* WBC greater than 4,000/mm\^3~* Absolute neutrophil count greater than 2,000/mm\^3~* Platelet count greater than 100,000/mm\^3~Hepatic:~* Bilirubin no greater than 1.25 times upper limit of normal (ULN)~* Prothrombin rate at least 70%~Renal:~* Creatinine no greater than 1.25 times ULN~* Creatinine clearance greater than 60 mL/min~Cardiovascular:~* No prior atrial or ventricular arrhythmias~* No prior congestive heart failure~* No myocardial infarction within the past 6 months~Other:~* Not pregnant or nursing~* Negative pregnancy test~* Fertile patients must use effective contraception~* No other prior or concurrent neoplasm except curatively treated nonmelanoma skin cancer or carcinoma in situ of the cervix~* No active infection~* No allergy to protocol drugs~* No dementia or significantly altered mental status~* No other serious medical condition that would prevent compliance~PRIOR CONCURRENT THERAPY:~Biologic therapy:~* No filgrastim (G-CSF) within 48 hours prior to chemotherapy~Chemotherapy:~* No prior chemotherapy~Endocrine therapy:~* Not specified~Radiotherapy:~* No prior radiotherapy~Surgery:~* See Disease Characteristics~* No prior stent implantation~* No prior laser therapy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 69 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: enrollment issues
Please assess the completion status of the following clinical trial:

Trial Title: Transcranial Infrared Laser Stimulation (TILS) of Prefrontal Cognition in Post-traumatic Stress Disorder (PTSD)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* War-zone and non-war-zone veterans~* Ages 18-60 years old~* Males and females~* Able to read, speak, and understand English~* Medical records showing prior diagnosis of PTSD (here it refers to the records prior to TILS, which will be assessed and obtained in Visit 1)~* Medical records showing diagnosis of PTSD (here it refers to the CAPS-5 record prior to TILS, which will be assessed and obtained in Visit 1)~* On stable doses of any psychotropic medications for at least 4 weeks~Exclusion Criteria:~* Significant physical disability to perform a computerized memory task~* Past/current significant medical/neurological/mental health disorders known to affect cognitive functioning (e.g., stroke, dementia, schizophrenia, AIDS)~* Presence of moderate/severe TBI, defined as having: alteration of consciousness/mental state \>24 hours; posttraumatic amnesia \>1 day; loss of consciousness \>30 minutes; and/or abnormal structural neuroimaging. We will not exclude veterans with mild TBI, which is found in nearly 50% of veterans with PTSD~* Alcohol abuse/dependence for the past 12- months, as determined by the Rapid Alcohol Problems Screen score \>0~* Drug abuse/dependence for the past 12- months, as determined by the Drug Abuse Screening Test-10 score \>2~* Severe depression (PHQ-9 total score \>19), significant risk of suicide (SBQ-R \>6), severe headache (PHQ-15, Item e =2), and/or severe dizziness (PHQ-15, Item g =2)~* Opiate use in the month prior to study entry

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- One TILS, one sham, and then five TILS interventions (Type: EXPERIMENTAL): Participants first received a TILS intervention, followed by a sham session one week later. Then, participants received another five weekly TILS interventions.
- One sham, then six TILS interventions (Type: EXPERIMENTAL): Participants first received a sham session, followed by six weekly TILS sessions.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: regulatory/approval
Please assess the completion status of the following clinical trial:

Trial Title: Change in Exercise Capacity as Measured by Peak Oxygen Uptake After CTO PCI

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients who present for percutaneous intervention of chronic total occlusion who are able and willing to perform treadmill cardiopulmonary stress testing before and after the intervention~Exclusion Criteria:~* Patients who present for percutaneous intervention of chronic total occlusion who are unable or unwilling to perform treadmill cardiopulmonary stress testing before and after the intervention

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: t

Study Arms:
- Asymptomatic (Type: None): Patients with known chronic total occlusion who are undergoing percutaneous coronary intervention wtih balloon angioplasty and coronary stent placement who are currently asymptomatic (without any chest pain or anginal equivalent) but have decreased exercise capacity or are easily fatigued. Patients will also be on dual antiplatelet therapy with aspirin and a second agent such as clopidogrel.
- Symptomatic (Type: None): Patients with known chronic total occlusion who are undergoing percutaneous coronary intervention with balloon angioplasty and coronary stent placement who are currently symptomatic with chest pain or anginal equivalent.. Patients will also be on dual antiplatelet therapy with aspirin and a second agent such as clopidogrel.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: enrollment issues
Please assess the completion status of the following clinical trial:

Trial Title: Functional and Anatomical MRI of the Spinal Cord and Peri-spinal Tissues

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: CROSS_SECTIONAL
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Elective Primary Coronary Artery Bypass Surgery~* Understanding and provision of written informed consent~* Age \> 18 and \< 75~* ASA class I, II or II~Exclusion Criteria:~Any combined or redo cardiac procedure~* Current alcohol or substance abuse~* Pre-existing chronic pain requiring chronic analgesic use~* Rest pain in proposed surgical area at baseline, preoperatively~* Chronic Steroid use~* Inability to perform post-operative assessments

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- No pain (Type: None): patients who are enrolled in the parent study and report no chest pain at their 6 month post-cardiac surgery follow-up will undergo functional and anatomical MRI
- Pain (Type: None): Patients who are enrolled in the parent study and report chest pain at their 6 month post-cardiac surgery follow-up will undergo functional and anatomical MRI

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: enrollment issues
Please assess the completion status of the following clinical trial:

Trial Title: Eating Behaviour and Quality of Life of Night Workers in Food and Nutrition Units

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~women; night workers; food service.~Exclusion Criteria:~male; pregnant; poorly or incomplete questionnaires.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Control (Type: NO_INTERVENTION): In this modality of intervention, the focus will be on the development of skills through educational actions in health, using the pedagogy of transmission. The focus will be based on content related to food, nutrition and quality of life. Materials like videos, áudios (podcasts), booklets and short films will be available weekly, following a schedule of sessions.
- Eating Behaviors (Type: EXPERIMENTAL): In the intervention group, the focus will be the development of skills through educational health actions that provide the development of autonomy and empowerment for behavior change, based on cognitive behavioral interventions, which involve eating behavior and impact on quality of life. Cognitive behavioral therapy (CBT) is based on ten principles that influence and / or determine treatment attitude and approach. Intervention group sessions will be based on principles.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: feasibility
Please assess the completion status of the following clinical trial:

Trial Title: A Study of GW856553X For the Treatment of Depression

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female = 18 years of age and \< 60 years,~* routine laboratory results within normal ranges,~* Body Mass Index within the range 18.5-35.0 kg/m2 inclusive.~* Subject must have had at least one previous major depressive episode with a diagnosis of MDD in his/her history, and had a successful pharmacological treatment of that episode, and is currently experiencing a recurrence of MDD presently un-medicated.~* Subjects must met the diagnosis of an episode of Major Depressive Disorder in the past 12 weeks but not greater than 24 months.~Exclusion Criteria:~* The subject has any history of liver disease.~* The subject has significant cardiac, pulmonary, metabolic, renal, hepatic or gastrointestinal conditions that, in the opinion of the investigator and/or GSK medical monitor, places the subject at an unacceptable risk as a participant in this trial.~* The subject has a history of autoimmune diseases.~* The subject has any active infectious diseases, including active tuberculosis or a history of active tuberculosis.~* The subject has a history of malignancy, except for surgically cured basal cell carcinoma or females with cured cervical carcinoma (\> 2 yrs prior).~* The subject has a history of HIV or other immunosuppressive disease.~* The subject has uncontrolled diabetes.~* The subject is pregnant or nursing.~* Subject has no contact with an adult on a daily basis (i.e., subjects who are not living with at least one other adult or subjects who do not have an adult who contacts them on a daily basis).~* Subject has initiated psychotherapy within three months prior to the Screening visit, or plans to initiate psychotherapy during the trial.~* Subject has received electroconvulsive therapy or transcranial magnetic stimulation or vagal nerve stimulation within the six months prior to the Screening.~* The subject is currently receiving a chronic biological or pharmacologic anti-inflammatory therapy; interferon therapy at any dose or did receive them within 6 months prior randomisation.~* Subjects who have donated a unit of blood within the previous month or intends to donate in the month after completing the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- Arm 1 (Type: EXPERIMENTAL): GW856553X 7.5mg BID for 6 weeks
- Placebo (Type: PLACEBO_COMPARATOR): Placebo to match, BID, 6 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: feasibility
Please assess the completion status of the following clinical trial:

Trial Title: Non-inferiority of Reduced-dose Rituximab in Rheumatoid Arthritis in Low Disease Activity and Remission

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of RA according to the 2010 American College of Rheumatology (ACR) / European League Against Rheumatism (EULAR) classification criteria~* Current treatment with RTX (at time of inclusion have already received at least 2 cycles of 1000mg RTX) at the Day-Clinic of the Division of Rheumatology of the Medical University of Vienna~* Persistent low disease activity or clinical remission as defined below~* Persistent clinical remission (pREM) will be defined as a simplified disease activity index (CDAI) (12) ≤2.8 measured at two time-points 6 months apart. The CDAI is calculated as follows: tender joint count (TJC) + swollen joint count (SJC) + patient's assessment of general health on a 100 mm visual analogue scale (GH) + evaluator's assessment of general health on a 100 mm visual analogue scale (EGH)~* Persistent low disease activity (pLDA) will be defined as a CDAI ≤10 measured at two timepoints 6 months apart Patients who achieve REM at only either one of the two successive time-points will be considered as having pLDA with regard to the current trial~Exclusion Criteria:~* Patients ≤ 18 yrs~* Patients receiving RTX for a disease other than RA~* Patients who fail to meet criteria for REM or LDA at either one of the two successive timepoints (i.e. having a disease activity \>10 as measured by the clinical disease activity index, (CDAI))

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 500mg RTX Group (Type: ACTIVE_COMPARATOR): Patients in this group will receive 1x500mg (500mg RTX group) RTX (Mabthera) at baseline (time-point of their upcoming semi-annual infusion) and at months 6, 12, 18 and 24
- 1000mg RTX group (Type: ACTIVE_COMPARATOR): Patients in this group will receive 1x1000mg RTX (Mabthera) at baseline (time-point of their upcoming semi-annual infusion) and at months 6, 12, 18 and 24

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: enrollment issues